"Interferon-gamma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
| Descriptor ID |
D007371
|
| MeSH Number(s) |
D12.644.276.374.440.893 D12.644.276.374.480.615.350 D12.776.467.374.440.893 D12.776.467.374.480.615.350 D23.529.374.440.893 D23.529.374.480.615.350
|
| Concept/Terms |
Interferon-gamma- Interferon-gamma
- gamma-Interferon
- Interferon, Immune
- Immune Interferon
- Type II Interferon
- Interferon, Type II
- Interferon Type II
- Interferon, gamma
|
Below are MeSH descriptors whose meaning is more general than "Interferon-gamma".
Below are MeSH descriptors whose meaning is more specific than "Interferon-gamma".
This graph shows the total number of publications written about "Interferon-gamma" by people in this website by year, and whether "Interferon-gamma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 5 | 6 |
| 1997 | 6 | 3 | 9 |
| 1998 | 4 | 1 | 5 |
| 1999 | 1 | 7 | 8 |
| 2000 | 1 | 3 | 4 |
| 2001 | 2 | 6 | 8 |
| 2002 | 5 | 11 | 16 |
| 2003 | 0 | 11 | 11 |
| 2004 | 8 | 6 | 14 |
| 2005 | 1 | 9 | 10 |
| 2006 | 7 | 12 | 19 |
| 2007 | 4 | 10 | 14 |
| 2008 | 8 | 8 | 16 |
| 2009 | 3 | 10 | 13 |
| 2010 | 2 | 13 | 15 |
| 2011 | 11 | 6 | 17 |
| 2012 | 1 | 16 | 17 |
| 2013 | 1 | 14 | 15 |
| 2014 | 4 | 7 | 11 |
| 2015 | 5 | 8 | 13 |
| 2016 | 4 | 8 | 12 |
| 2017 | 2 | 14 | 16 |
| 2018 | 0 | 13 | 13 |
| 2019 | 5 | 5 | 10 |
| 2020 | 4 | 11 | 15 |
| 2021 | 0 | 5 | 5 |
| 2022 | 1 | 5 | 6 |
| 2023 | 1 | 3 | 4 |
| 2024 | 4 | 3 | 7 |
| 2025 | 1 | 6 | 7 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon-gamma" by people in Profiles.
-
CD8 TRM-like T cells expressing perforin and IFN-? define a pediatric activated T-cell acute liver failure endotype. Hepatol Commun. 2026 Apr 01; 10(4).
-
Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice. Nat Microbiol. 2026 Apr; 11(4):1064-1079.
-
Estrogen Induced Regulation of Mucosal-Associated Invariant T Cells in Asthma. J Immunol Res. 2026; 2026(1):e8201923.
-
Signal Transducer and Activator of Transcription (STAT) Proteins Regulate Mucosal-Associated Invariant T (MAIT) Cell Function. Immunology. 2026 05; 178(1):97-108.
-
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors. Nat Commun. 2025 Dec 09; 16(1):10987.
-
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial. Infection. 2026 Feb; 54(1):473-485.
-
The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria. PLoS One. 2025; 20(10):e0333647.
-
C-C motif chemokine receptor-like 2 promotes the interferon-? signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53. Haematologica. 2026 Feb 01; 111(2):493-507.
-
Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections. Nat Biomed Eng. 2026 Jan; 10(1):69-79.
-
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles. Cancer Biol Ther. 2025 Dec; 26(1):2455722.